- Prophylactic mastectomy in BRCA carriers from point of view of plastic surgery2018 | Faculty of Medicine in Pilsen
- The issue of BRCA mutations on clinical point of view2016 | Third Faculty of Medicine
- BRCA-positive ovarian cancer - case report +12020 | Third Faculty of Medicine
- Detection and Incidence of Mutations of BRCA 1 Gene in patients with Cancer of the breast and Ovarz.2003 | First Faculty of Medicine
- Satisfaction and overall quality of life in BRCA positive women after prophylactic surgeries2017 | First Faculty of Medicine
- The mutation analysis of gene BRCA 1 in families with genetic risk of breast and ovarian carcinoma2000 | First Faculty of Medicine
- PARP inhibitor olaparib great benefit for a defined group of patients with BRCA positive ovarian cancer2019 | Faculty of Medicine in Pilsen
- BRCA1 and BRCA: Genetic testing and what next - Commentary2002 | Publication without faculty affiliation
- Hereditary risk of ovarian cancer and its prophylactic measures2018 | Faculty of Medicine in Pilsen
- Ovarian cancer - hereditary disposition2018 | Faculty of Medicine in Pilsen
- Brest cancer2018 | Third Faculty of Medicine
- Niraparib expands the availability of maintenance therapy in patients with advanced high-grade ovarian cancer2022 | Faculty of Medicine in Pilsen
- Zárodečná mutace BRCA jako nový léčebný cíl2020 | First Faculty of Medicine
- Overview on population screening for carriers with germline BRCA mutation in China2022 | Faculty of Medicine in Pilsen
- Mutace BRCA jako podmínka pro indikaci cílené léčby karcinomu prsu2019 | First Faculty of Medicine
- Land use changes in the inner central-bohemian periphery - Břekova LhotaPublication without faculty affiliation
- Anti-Müllerian hormone – clinical use and future possibilities2023 | First Faculty of Medicine
- Detection of germ-line mutation in the BRCA 1 gene by the protein truncation test.1999 | Faculty of Physical Education and Sport
- Can be considered the primary fallopian tube cancer an enigma at the beginning of the third millenium?2013 | Faculty of Medicine in Hradec Králové
- Therapeutic options in patients with early breast cancer2023 | First Faculty of Medicine
- BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinduction2023 | First Faculty of Medicine, Third Faculty of Medicine
- Mutation analysis of BRCA genes in hereditary breast cancersPublication without faculty affiliation
- European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerPublication without faculty affiliation
- Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.2011 | First Faculty of Medicine
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian CancerPublication without faculty affiliation
- Mutation of the BRCA 1 Gene in Hereditary Breast and varian Cancer in the Czech Republic2003 | First Faculty of Medicine
- High frequency of BRCA 1/2 and p53 somatic inactivation in sporadic ovarian cancer2007 | First Faculty of Medicine
- Mutation of the BRCA 1 Gene in Hereditary Breast and varian Cancer in the Czech Republic2003 | Faculty of Physical Education and Sport
- Paraneoplastic hypercalcaemia in a female patient with tumor duplicity of ovarian and breast carcinoma2006 | First Faculty of Medicine
